Literature DB >> 16122776

Suppression of hepatitis B virus replication by SRPK1 and SRPK2 via a pathway independent of the phosphorylation of the viral core protein.

Yanyan Zheng1, Xiang-dong Fu, J-H James Ou.   

Abstract

The SR-domain protein kinase (SRPK) 1 and 2 are two important kinases involved in cellular RNA splicing. Recently, it was suggested that these two kinases, which could bind to the hepatitis B virus (HBV) core protein, might be the major cellular kinases that phosphorylate the core protein to regulate HBV replication. In this report, we tested the role of SRPK1 and SRPK2 in HBV replication and found that both of them could suppress HBV replication by reducing the packaging efficiency of the pgRNA without affecting the formation of the viral core particles. This suppressive effect of SRPK1 and SRPK2 on HBV replication cannot be explained by their phosphorylation activities on the HBV core protein as the over-expression of these two kinases had no detectable effects on HBV core protein phosphorylation in vivo and their mutants that lacked the kinase activity could still suppress HBV DNA replication. Thus, these findings demonstrate a negative role of SRPK1 and SRPK2 in the regulation of HBV replication through a mechanism not involving the phosphorylation of the core protein.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16122776     DOI: 10.1016/j.virol.2005.07.030

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  25 in total

Review 1.  The diverse functions of the hepatitis B core/capsid protein (HBc) in the viral life cycle: Implications for the development of HBc-targeting antivirals.

Authors:  Ahmed Diab; Adrien Foca; Fabien Zoulim; David Durantel; Ourania Andrisani
Journal:  Antiviral Res       Date:  2017-11-26       Impact factor: 5.970

2.  Full-length hepatitis B virus core protein packages viral and heterologous RNA with similarly high levels of cooperativity.

Authors:  J Zachary Porterfield; Mary Savari Dhason; Daniel D Loeb; Michael Nassal; Stephen J Stray; Adam Zlotnick
Journal:  J Virol       Date:  2010-04-28       Impact factor: 5.103

3.  Interferons accelerate decay of replication-competent nucleocapsids of hepatitis B virus.

Authors:  Chunxiao Xu; Haitao Guo; Xiao-Ben Pan; Richeng Mao; Wenquan Yu; Xiaodong Xu; Lai Wei; Jinhong Chang; Timothy M Block; Ju-Tao Guo
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

Review 4.  Core protein: A pleiotropic keystone in the HBV lifecycle.

Authors:  Adam Zlotnick; Balasubramanian Venkatakrishnan; Zhenning Tan; Eric Lewellyn; William Turner; Samson Francis
Journal:  Antiviral Res       Date:  2015-06-27       Impact factor: 5.970

5.  Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma.

Authors:  Robert J Clifford; Jinghui Zhang; Daoud M Meerzaman; Myung-Soo Lyu; Ying Hu; Constance M Cultraro; Richard P Finney; Jenny M Kelley; Sol Efroni; Sharon I Greenblum; Cu V Nguyen; William L Rowe; Sweta Sharma; Gang Wu; Chunhua Yan; Hongen Zhang; Young-Hwa Chung; Jeong A Kim; Neung Hwa Park; Il Han Song; Kenneth H Buetow
Journal:  Hepatology       Date:  2010-12       Impact factor: 17.425

6.  Encapsidated hepatitis B virus reverse transcriptase is poised on an ordered RNA lattice.

Authors:  Joseph Che-Yen Wang; David G Nickens; Thomas B Lentz; Daniel D Loeb; Adam Zlotnick
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-17       Impact factor: 11.205

7.  An inhibitor of viral RNA replication is encoded by a plant resistance gene.

Authors:  Kazuhiro Ishibashi; Kiyoshi Masuda; Satoshi Naito; Tetsuo Meshi; Masayuki Ishikawa
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-15       Impact factor: 11.205

Review 8.  Virological Basis for the Cure of Chronic Hepatitis B.

Authors:  Jin Hu; Junjun Cheng; Liudi Tang; Zhanying Hu; Yue Luo; Yuhuan Li; Tianlun Zhou; Jinhong Chang; Ju-Tao Guo
Journal:  ACS Infect Dis       Date:  2018-06-25       Impact factor: 5.084

Review 9.  Targeting the multifunctional HBV core protein as a potential cure for chronic hepatitis B.

Authors:  Usha Viswanathan; Nagraj Mani; Zhanying Hu; Haiqun Ban; Yanming Du; Jin Hu; Jinhong Chang; Ju-Tao Guo
Journal:  Antiviral Res       Date:  2020-08-17       Impact factor: 5.970

10.  Cyclin-dependent kinase 2 phosphorylates s/t-p sites in the hepadnavirus core protein C-terminal domain and is incorporated into viral capsids.

Authors:  Laurie Ludgate; Xiaojun Ning; David H Nguyen; Christina Adams; Laura Mentzer; Jianming Hu
Journal:  J Virol       Date:  2012-09-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.